HI PHARMACEUTICAL LTD
Company number SC721693 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HI PHARMACEUTICAL LTD - Analysis Report
Company Number: SC721693
Analysis Date: 2025-07-29 19:12 UTC
Risk Rating: MEDIUM
The company shows a significant decline in net current assets and net assets over the most recent year, indicating potential solvency and liquidity concerns. However, it remains solvent on a balance sheet basis with positive net assets.Key Concerns:
- Declining Net Current Assets: Net current assets dropped from £9,637 in 2023 to £2,425 in 2024, suggesting reduced liquidity.
- Small Scale Operation: Micro-entity status with only one employee and limited asset base implies vulnerability to operational disruptions or cash flow volatility.
- Single Director and PSC Concentration: The sole director and 100% controlling shareholder is the same individual, which could pose governance and succession risks.
- Positive Indicators:
- Compliance with Filing Requirements: All statutory accounts and confirmation statements are up to date with no overdue filings.
- Solvent Position: Despite decline, the company maintains positive shareholder funds and net assets, indicating it can currently meet liabilities.
- Clear Ownership and Control: Ownership and control are transparent, reducing risks related to hidden interests or complex structures.
- Due Diligence Notes:
- Investigate reasons behind the sharp reduction in current assets and net assets over the 2024 financial year.
- Review cash flow statements and working capital management to assess liquidity trends and ability to meet short-term obligations.
- Confirm operational viability given the micro-entity scale and single employee structure, including any plans for scaling or diversification.
- Assess director’s background and capability, given sole control, and any related-party transactions or risks.
- Verify that no undisclosed contingent liabilities or regulatory issues exist, as none are evident from current filings.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.